Epidémioiogie des cancers, Bull Cancer, vol.84, issue.9, pp.917-925, 1997. ,
Cancer incidence and mortality in France in 1975???95, European Journal of Cancer Prevention, vol.6, issue.5, pp.442-66, 1997. ,
DOI : 10.1097/00008469-199710000-00005
Variations géographiques et temporelles de la mortalité par cancer bronchique en France. in 19ème réunion scientifique de l'Associatton des Epidémiologistes de Langue Française, 1994. ,
Survival ofcancer patients in Europe ,
Lyon: Scientific Publications. 6. Roffo, A.H., Der Tabakals krebserzeugendeAgens, Dtsch Med Wochnschr, vol.63, pp.1267-71, 1937. ,
Krebserzeugendes Benzpyren, gewonnen aus Tabakteer, Zeitschrift f??r Krebsforschung, vol.30, issue.5, pp.588-97, 1939. ,
DOI : 10.1042/bj0300704
Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study ofsix hundred and eighty-four proved cases, Jama, issue.143, pp.329-375, 1950. ,
A study ofthe aetiology ofcarcinoma ofthe lung, BMJ, issue.2, pp.1271-86, 1952. ,
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers., Journal of Epidemiology & Community Health, vol.32, issue.4, pp.303-316, 1978. ,
DOI : 10.1136/jech.32.4.303
Patterns of lung cancer risk according to type of cigarette smoked, International Journal of Cancer, vol.62, issue.5, pp.569-76, 1984. ,
DOI : 10.1002/ijc.2910330504
Mortality in relation to smoking: 40 years' observations on male British doctors, BMJ, vol.309, issue.6959, pp.901-912, 1994. ,
DOI : 10.1136/bmj.309.6959.901
Le tabagisme: de la prévention au sevrage. Abrégés, 1997. ,
Residential radon exposure and lung cancer in Sweden, Radon et cancer bronchique primitif Rev Mal Respir N Engl J Med, vol.11, issue.153, pp.531-576, 1994. ,
A meta-analysis of epidemiologic studies of lung cancer in welders, Scandinavian Journal of Work, Environment & Health, vol.23, issue.2, pp.104-117, 1997. ,
DOI : 10.5271/sjweh.187
Revisions in the International System for Staging Lung Cancer, Chest, vol.111, issue.6, pp.1710-1717, 1997. ,
DOI : 10.1378/chest.111.6.1710
Management of non-small cell lung cancer with direct mediastinal involvement, The Annals of Thoracic Surgery, vol.58, issue.5, pp.1447-51, 1994. ,
DOI : 10.1016/0003-4975(94)91933-X
Current Status of Surgical Resection for Lung Cancer, Chest, vol.106, issue.6, pp.337-339, 1994. ,
DOI : 10.1378/chest.106.6_Supplement.337S
1sfollow-up oflung cancer patients af/er resection medically indicated and costeffective? Ann Thorac Surg, pp.1563-70, 1995. ,
DOI : 10.1016/0003-4975(95)00893-4
Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent Disease, The Annals of Thoracic Surgery, vol.38, issue.4, pp.331-339, 1984. ,
DOI : 10.1016/S0003-4975(10)62281-3
tobacco smoking and pulmonary complications af/er surgery Preoperative prediction ofpulmonary complications following thoracic surgery, Lancet Chest, vol.23, issue.1041, pp.368-70, 1944. ,
Long-term results of operation for non-small cell lung cancer in the elderly, The Annals of Thoracic Surgery, vol.50, issue.6, pp.919-941, 1990. ,
DOI : 10.1016/0003-4975(90)91119-V
Prognostic assessment of 1310 patients with non???small-cell lung cancer who underwent complete resection from 1980 to 1993, The Journal of Thoracic and Cardiovascular Surgery, vol.116, issue.3, pp.407-418, 1998. ,
DOI : 10.1016/S0022-5223(98)70006-6
Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group, Cancer, vol.44, issue.9, pp.1802-1815, 1984. ,
DOI : 10.1016/0014-2964(79)90291-3
Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung, The American Journal of Surgical Pathology, vol.8, issue.5, pp.357-65, 1984. ,
DOI : 10.1097/00000478-198405000-00004
Prognosticfactors in resected stages 1 and 11adenocarcinoma ofthe lung. A multivariate regression analysis of137 consecutive patients, J Thorac Cardiovasc Surg, vol.99, issue.2, pp.218-244, 1990. ,
Roentgenographic Evaluation of Mediastinal Nodes for Preoperative Assessment in Lung Cancer, Chest, vol.88, issue.2, pp.206-216, 1985. ,
DOI : 10.1378/chest.88.2.206
Direct lymphatic drainage oflung segments to the mediastinal nodes An anatomie study on 260 adults Randomized trial oflobectomy versus limited resectionfor Tl NO non-small ceillung cancer. Lung Cancer Study Group, J Thorac Cardiovasc Surg Ann Thorac Surg, vol.97, issue.833, pp.623-655, 1989. ,
Accuracy ofcomputed tomographie scan and surgical assessmentfor staging of bronchial carcinoma. A prospective study, J Thorac Cardiovasc Surg, vol.104, issue.2, pp.413-433, 1992. ,
Can computed tomography of the chest stage lung cancer????Yes and no, The Annals of Thoracic Surgery, vol.49, issue.4, pp.591-596, 1990. ,
DOI : 10.1016/0003-4975(90)90306-Q
Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma, Regionallymph node classification for lung cancer staging. Chest, pp.224-7111, 1997. ,
DOI : 10.1016/S1010-7940(97)00084-5
Chirurgie du carcinome bronchique avec envahissement nodulaire médiastinal, Ann Chir, vol.48, issue.9, pp.852-61, 1994. ,
Significance ofpositive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer ofthelung Prognosis ofunsuspected but completely resectable N2 non-small celliung cancer, J Thorac Cardiovasc Surg Ann Thorac Surg, vol.83, issue.12, pp.56-300, 1982. ,
Prognostic significance ofNI disease in carcinoma ofthe lung, J Thorac Cardiovasc Surg, vol.86, issue.5, pp.646-53, 1983. ,
Irradiation complémentaire pour cancer bronchique, Ann Chir, vol.40, issue.2, pp.89-95, 1986. ,
Results ofresectionfor bronchogenic carcinoma with mediastinallymph node metastases in selected patients Validation ofthe TNM classification (4th edn) for lung cancer: first results ofa prospective study of 1086 patients with surgicaltreatment, Eur J Cardiothorac Surg Eur J Cardiothorac Surg, issue.511 57, pp.583-589, 1991. ,
Résultats de la chirurgie du cancer bronchique non anaplasique Analyse critique de la survie, Ann Chir, issue.6, pp.41-469, 1987. ,
Incidence of local recurrence and second primary tumors in resected stage I lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.109, issue.1, pp.120-129, 1995. ,
DOI : 10.1016/S0022-5223(95)70427-2
Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node Metastases, Annals of Surgery, vol.198, issue.3, pp.386-97, 1983. ,
DOI : 10.1097/00000658-198309000-00015
Modern thirty-day operative mortality for surgical resections in lung cancer, J Thorac Cardiovasc Surg, vol.86, issue.5, pp.654-662, 1983. ,
Complications et mortalité de la chirurgie du cancer bronchique, Rev Pneumol Clin, vol.48, issue.5, pp.231-237, 1992. ,
Pulmonary Complications Following Lung Resection, Chest, vol.118, issue.5, pp.1263-70, 2000. ,
DOI : 10.1378/chest.118.5.1263
Hermann: Science et pratique médicales Clinical dose response curves ofhuman malignant epithelialtumours, Br J Radiol, vol.102, issue.542, pp.46-151, 1973. ,
Impact ofirradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma ofthe lung: report by the Radiation Therapy Oncology Group. Cancer, l04. ICRU, Prescribing, Recording and Reporting Photon Beam therapy. 1993, International Comission on Radiation Units and Measurements: Bethesda. 105. ICRU, Prescribing, Recording and Reporting Photon Beam therapy International Comission on Radiation Units and Measurements: Bethesda, pp.1091-1100, 1982. ,
Radiothérapie du cancer bronchique non à petites cellules: définitions des volumes, sélection des patients Recommendations de l'International Associationfor the Study ofLung Cancer l8F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis, Cancer Radiother Int J Radiat Oncol Biol Phys, issue.253, pp.579-8944, 1998. ,
Apport de la tomographie par émission de positons à la radiothérapie thoracique, Cancer Radiother, issue.4Supp11, pp.13-19, 2000. ,
The impact of(l8)F-jluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small celliung cancer, Radiother Oncol, issue.3, pp.55-317, 2000. ,
CT and (18)F-deoxyglucose (FDG) image fusion for optimization ofcorformal radiotherapy oflung cancers, 1nt J Radiat Onco1 Biol Phys, issue.5, pp.49-1249, 2001. ,
Evaluation of microscopic tumor extension in non???small-cell lung cancer for three-dimensional conformal radiotherapy planning, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.4, pp.1015-1039, 2000. ,
DOI : 10.1016/S0360-3016(00)00750-1
Evaluation ofmicroscopie tumor extension in non-small-celliung cancer for three-dimensional conformal radiotherapy planning, URGBP Int J Radiat Oncol Biol Phys, vol.48, issue.534, pp.1015-1024, 2000. ,
Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography, International Journal of Radiation Oncology*Biology*Physics, vol.18, issue.3, pp.671-678, 1990. ,
DOI : 10.1016/0360-3016(90)90076-V
Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.4, pp.1081-92, 2001. ,
DOI : 10.1016/S0360-3016(01)01766-7
What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol, pp.71-77, 1998. ,
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.53, issue.4, pp.822-856, 2002. ,
DOI : 10.1016/S0360-3016(02)02803-1
Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer, Radiotherapy and Oncology, vol.66, issue.1, pp.75-85, 2003. ,
DOI : 10.1016/S0167-8140(02)00287-6
Electronic Portal Imaging with On-Line Correction of Setup Error in Thoracic Irradiation: Clinical Evaluation, International Journal of Radiation OncologyBiologyPhysics, vol.40, issue.4, pp.967-76, 1998. ,
DOI : 10.1016/S0360-3016(97)00925-5
Accuracy of set-up of thoracic radiotherapy: prospective analysis of 24 patients treated with radiotherapy for lung cancer, The British Journal of Radiology, vol.75, issue.890, pp.162-171, 2002. ,
DOI : 10.1016/S0360-3016(00)00625-8
Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.1, pp.211-217, 1999. ,
DOI : 10.1016/S0360-3016(98)00354-X
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.2, pp.348-56, 2002. ,
DOI : 10.1016/S0360-3016(02)02958-9
Has 3-D conformai radiotherapy (3D CRT) improved the local tumour control for stage 1 non-small celliung cancer? Radiother Oncol, pp.151-158, 2002. ,
Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.33, issue.5, pp.993-1000, 1995. ,
DOI : 10.1016/0360-3016(95)02016-0
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer, Radiotherapy and Oncology, vol.44, issue.1, pp.17-22, 1997. ,
DOI : 10.1016/S0167-8140(97)01907-5
The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.33, issue.5, pp.1001-1008, 1995. ,
DOI : 10.1016/0360-3016(95)02010-1
Volume tumoral macroscopique et volume???cible anatomoclinique en radioth??rapie??: cancer bronchique, Cancer/Radioth??rapie, vol.5, issue.5, pp.659-70, 2001. ,
DOI : 10.1016/S1278-3218(01)00124-X
Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma, Cancer, vol.62, issue.7, pp.1159-64, 1999. ,
DOI : 10.1148/radiology.203.1.9122391
Dose escalation for non-small cell lung cancer using conformal radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.37, issue.5, pp.1079-85, 1997. ,
DOI : 10.1016/S0360-3016(96)00593-7
Radiotherapy Alone for Medically Inoperable Stage I Non-Small???Cell Lung Cancer: The Duke Experience, International Journal of Radiation OncologyBiologyPhysics, vol.40, issue.1, pp.149-54, 1998. ,
DOI : 10.1016/S0360-3016(97)00589-0
Involved-field radiotherapy alone for early-stage non???small-cell lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.3, pp.703-713, 2000. ,
DOI : 10.1016/S0360-3016(00)00667-2
Elective nodal irradiation in the treatment of non???small-cell lung cancer with three-dimensional conformal radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.50, issue.3, pp.681-686, 2001. ,
DOI : 10.1016/S0360-3016(01)01482-1
Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?, International Journal of Radiation Oncology*Biology*Physics, vol.34, issue.2, pp.297-302, 1996. ,
DOI : 10.1016/0360-3016(95)00227-8
Can elective nodal irradiation be omitted in stage III non-small-celliung cancer? Analysis ofrecurrences in a phase 11study ofinduction chemotherapy and involved-field radiotherapy ,
Estimation de la probabilit?? d???envahissement tumoral m??diastinal??: une d??finition statistique du volume???cible anatomoclinique pour la radioth??rapie conformationnelle des cancers bronchiques non ?? petites cellules???, Cancer/Radioth??rapie, vol.5, issue.6, pp.725-761, 2001. ,
DOI : 10.1016/S1278-3218(01)00135-4
Target volume definition for three-dimensional conformai radiation therapy oflung cancer, Br J Radial, issue.846, pp.71-587, 1998. ,
The use of active breathing control (ABC) to reduce margin for breathing motion, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.4, pp.911-919, 1999. ,
DOI : 10.1016/S0360-3016(99)00056-5
Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.3, pp.603-614, 1999. ,
DOI : 10.1016/S0360-3016(99)00154-6
The deep inspiration breath-hold technique in the treatment of inoperable non???small-cell lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.1, pp.81-88, 2000. ,
DOI : 10.1016/S0360-3016(00)00583-6
Radioth??rapie des cancers du poumon??: le blocage en inspiration sous contr??le spirom??trique, Cancer/Radioth??rapie, vol.6, issue.1, pp.30-38, 2002. ,
DOI : 10.1016/S1278-3218(01)00132-9
Held-breath self-gating technique for radiotherapy of non???small-cell lung cancer: A feasibility study, International Journal of Radiation Oncology*Biology*Physics, vol.49, issue.1, pp.43-52, 2001. ,
DOI : 10.1016/S0360-3016(00)01372-9
Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging, International Journal of Radiation Oncology*Biology*Physics, vol.52, issue.2, pp.522-531, 2002. ,
DOI : 10.1016/S0360-3016(01)02681-5
Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer, Lung Cancer, vol.11, issue.3-4, pp.153-78, 1994. ,
DOI : 10.1016/0169-5002(94)90537-1
Current Strategies for Radiation Therapy in Non-small Cell Lung Cancer, Chest, vol.112, issue.4, pp.209-213, 1997. ,
DOI : 10.1378/chest.112.4_Supplement.209S
Comparison oftreatment policies in inoperable branchial carcinoma, Lancet, issue.17702, pp.715-724, 1971. ,
The Survival of Patients with Inoperable Lung Cancer: A Large-Scale Randomized Study of Radiation Therapy Versus Placebo, Radiology, vol.90, issue.4, pp.688-97, 1968. ,
DOI : 10.1148/90.4.688
Three-dimensional treatment planning for lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.1, pp.217-227, 1991. ,
DOI : 10.1016/0360-3016(91)90180-C
Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis, International Journal of Radiation Oncology*Biology*Physics, vol.27, issue.2, pp.273-84, 1993. ,
DOI : 10.1016/0360-3016(93)90238-Q
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11., Journal of Clinical Oncology, vol.8, issue.9, pp.1543-55, 1990. ,
DOI : 10.1200/JCO.1990.8.9.1543
Interruptions ofhigh-dose radiation therapy decrease long-term survival offavorable patients with unresectable non-small cell carcinoma ofthe lung: analysis of 1244 casesfrom 3 ,
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer, JNCI Journal of the National Cancer Institute, vol.87, issue.3, pp.198-205, 1995. ,
DOI : 10.1093/jnci/87.3.198
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer, Chest, vol.117, issue.2, pp.358-64, 2000. ,
DOI : 10.1378/chest.117.2.358
Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials, International Journal of Radiation Oncology*Biology*Physics, vol.37, issue.2, pp.259-67, 1997. ,
DOI : 10.1016/S0360-3016(96)00511-1
CHART) in non-small cell carcinoma ofthe bronchus Experience with CHART Continuo us hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-smali-ceillung cancer: a randomised multicentre trial Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-smali-ceillung cancer, lnt J Radial Oncol Biol Phys Int J Radial Oncol Biol Phys CHART Steering Commit/ee. Lancet Br J Cancer, vol.19350, issue.213907210, pp.1211-578, 1990. ,
Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment oflocally advanced non-small ceillung cancer, Clin Oncol (R Coll Radial), issue.5, pp.14-352, 2002. ,
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small ceillung cancer: mature data from the randomised multicentre trial, CHARTSteeringcommit/ee. RadiolherOncol, vol.52, issue.2, pp.137-185, 1999. ,
Dose escalation in non-small-cell lung cancer using three-dimensional conformai radiation therapy: update ofa phase !trial, J Clin Oncol, vol.19, issue.1, 2001. ,
Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study., Journal of Clinical Oncology, vol.14, issue.4, pp.1065-70, 1996. ,
DOI : 10.1200/JCO.1996.14.4.1065
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma, Cancer, vol.36, issue.6, pp.1037-1085, 1998. ,
DOI : 10.1002/(SICI)1097-0142(19980315)82:6<1037::AID-CNCR5>3.0.CO;2-B
A phase 1/1study ofaccelerated radiotherapy with and without carboplatin in nonsmall celliung cancer: an interim toxicity analysis ofthe first 100 patients, Int J Radial Oncol Biol Phys, issue.2, pp.31-267, 1995. ,
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous celliung cancer: failure patterns by cell type in RTOG 88-081ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group, Int J Radial Oncol Biol Phys, issue.3, pp.39-537, 1997. ,
Randomized phase /1 study ofcisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage I/1B non-small-cell lung cancer: cancer and leukemia group B study 9431, J Clin Oncol, issue.20, pp.20-4191, 2002. ,
Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non???Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504, Journal of Clinical Oncology, vol.21, issue.10, pp.2004-2014, 2003. ,
DOI : 10.1200/JCO.2003.04.197
[What are the optimal thoracic radiotherapy modalities in limited small celliung cancer? Review ofrecent clinical trials, Cancer Radiother, pp.513-520, 1999. ,
Clinical dose???volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.2, pp.323-332, 1999. ,
DOI : 10.1016/S0360-3016(99)00183-2
Physical and biological predictors ofchanges in whole-Iungfunctionfollowing thoracic irradiation, pp.563-570, 1997. ,
Radiation pneumonitis as afunction ofmean lung dose: an analysis ofpooled data of540 patients, pp.1-9, 1998. ,
DOI : 10.1016/s0360-3016(98)00196-5
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.2, pp.329-368, 2002. ,
DOI : 10.1016/S0360-3016(02)02929-2
Comparing difJerent NTCP models that predict the incidence ofradiation pneumonitis. Normal tissue complication probability, Int J Radiat Oncol Biol Phys, issue.3, pp.55-724, 2003. ,
Changes in plasma TGF?? levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis, International Journal of Radiation Oncology*Biology*Physics, vol.30, issue.3, pp.671-677, 1994. ,
DOI : 10.1016/0360-3016(92)90954-G
TGF-beta, radiation-induced pulmonary injury and lung cancer, International Journal of Radiation Biology, vol.76, issue.4, pp.511-517, 2000. ,
DOI : 10.1080/095530000138510
Clinical and dosimetric predictors of radiation-induced esophageal toxicity, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.1, pp.97-103, 1999. ,
DOI : 10.1016/S0360-3016(99)00163-7
Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.2, pp.291-296, 2001. ,
DOI : 10.1016/S0360-3016(01)01648-0
Beam intensity modulation for penumbra enhancement in the treatment of lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.2, pp.449-54, 1999. ,
DOI : 10.1016/S0360-3016(98)00563-X
Beam intensity modulation for penumbra enhancement and field length reduction in lung cancer treatments: a dosimetric study, Radiotherapy and Oncology, vol.56, issue.2, pp.181-189, 2000. ,
DOI : 10.1016/S0167-8140(00)00188-2
Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: a dosimetric study, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.4, pp.893-904, 1999. ,
DOI : 10.1016/S0360-3016(98)00489-1
An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer, Lung Cancer, vol.32, issue.2, pp.145-53, 2001. ,
DOI : 10.1016/S0169-5002(00)00214-2
Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer, Radiotherapy and Oncology, vol.45, issue.3, pp.253-61, 1997. ,
DOI : 10.1016/S0167-8140(97)00132-1
Conformal radiotherapy of stage III non???small cell lung cancer: a class solution involving non???coplanar intensity-modulated beams, International Journal of Radiation Oncology*Biology*Physics, vol.41, issue.4, pp.771-778, 1998. ,
DOI : 10.1016/S0360-3016(98)00114-X
totalité de l'acquisition) et l' oesophage (tous les 2 cm , totalité de la structure) ,
RX DE 10 MV DE PREFERENCE Les faisceaux et les caches sont déterminés autour des PTV et ne dépendent plus que de la géométrie du faisceau ,
Simulation virtuelle: séance bianche Actuellement 1 controle par champ suffit si la marge de repositionnement est respectée ,
The impact of three-dimensional radiation on the treatment of non-small cell lung cancer, Radiotherapy and Oncology, vol.56, issue.2, pp.157-67, 2000. ,
DOI : 10.1016/S0167-8140(00)00207-3
Derni??res recommandations de l'ICRU pour la prescription, l'enregistrement et le compte rendu de la radioth??rapie externe, Cancer/Radioth??rapie, vol.2, issue.5, pp.607-621, 1998. ,
DOI : 10.1016/S1278-3218(98)80104-2
What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?, Radiotherapy and Oncology, vol.48, issue.1, pp.71-78, 1998. ,
DOI : 10.1016/S0167-8140(98)00046-2
Tolerance of normal tissue to therapeutic irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.1, pp.109-131, 1991. ,
DOI : 10.1016/0360-3016(91)90171-Y
Clinical dose???volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.2, pp.323-332, 1999. ,
DOI : 10.1016/S0360-3016(99)00183-2
Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.1, pp.211-217, 1999. ,
DOI : 10.1016/S0360-3016(98)00354-X
Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.5, pp.1169-76, 1998. ,
DOI : 10.1016/S0360-3016(98)00239-9
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.1, pp.1-9, 1998. ,
DOI : 10.1016/S0360-3016(98)00196-5
Evaluation dosim??trique d'une radioth??rapie conformationnelle: le facteur de conformation, Cancer/Radioth??rapie, vol.4, issue.3, pp.207-223, 2000. ,
DOI : 10.1016/S1278-3218(00)89096-4